Sorted By:

Relevance


Patient Assistance Programs for HIV Get Boost from HHS Secretary Sebelius

PhRMA  |  Press Release

“Our industry looks forward to working with Secretary Sebelius to make sure that those without access to medicines for HIV will be able to get what they need.”
https://www.phrma.org/press-release/patient-assistance-programs-for-hiv-get-boost-from-hhs-secretary-sebelius

Medicines have significantly increased chances of cancer survival around the globe

PhRMA  |  Blog Post

New treatments continue to alter the course of previously fatal diseases and there are now more promising cancer medicines in the pipeline than at any time in history.
http://catalyst.phrma.org/medicines-have-significantly-increased-chances-of-cancer-survival-around-the-globe

RxE HCV in New Hampshire

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-new-hampshire

RxE HCV in New Mexico

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-new-mexico

Hepatitis C (HCV): Cure Rates Are Rising

Chartpack  |  From Our Network

Looking ahead to the next generation, we may be able to eliminate this disease due to medicine.
http://chartpack.phrma.org/biophrma-chartpack/advances-in-treatment/hepatitis-c-hcv-cure-rates-are-rising

RxE HCV in New York

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-new-york

Celebrating tremendous advances in HIV/AIDS on National Youth HIV/AIDS Awareness Day

PhRMA  |  Blog Post

In fact, for those diagnosed with HIV at the age of 20, they can expect to live to the age of 70, which is the average life expectancy for the U.S. population as a whole.
http://catalyst.phrma.org/celebrating-tremendous-advances-in-hiv/aids-on-national-youth-hiv/aids-awareness-day

HIV/AIDS: Treatment Advances Build Over Time

Chartpack  |  From Our Network

Over the past 30 years, the death rate for AIDS dramatically declined due to a series of treatment advances rather than a single breakthrough. 
http://chartpack.phrma.org/2016-perspective/chapter-1/hiv/aids-treatment-advances-build-over-time

Medicines in Development for Parkinson's Disease 2014 Report

PhRMA  |  Report

Parkinson’s disease is the 14th leading cause of death in the United States.
https://www.phrma.org/report/medicines-in-development-for-parkinson-s-disease-2014-report

Medicines in Development for Rare Diseases

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/medicines-in-development-for-rare-diseases

Burden on Patients: Two Steps Forward and One Step Back for HIV/AIDS Patients

PhRMA  |  Blog Post

” It has been a long road to finding successful treatments for suppressing and managing HIV/AIDS.
http://catalyst.phrma.org/burden-on-patients-two-steps-forward-and-one-step-back-for-hiv/aids-patients

Infectious diseases were the leading cause of death in the United States until the 1920s

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested approximately $550 billion in the search for new treatments and cures, including an estimated $48.5 billion in 2012 alone.
https://www.phrma.org/press-release/infectious-diseases-were-the-leading-cause-of-death-in-the-united-states-until-the-1920s

RxE HCV in California

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-california

RxE HCV in Pennsylvania

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-pennsylvania

Putting the bio in biotech: How Bay Area minds are powering biopharmaceutical innovation

PhRMA  |  Blog Post

Join us via livestream on Tuesday, August 1, from 8am – 11am PST to hear firsthand from this notable group of leading minds.
http://catalyst.phrma.org/putting-the-bio-in-biotech-how-bay-area-minds-are-powering-biopharmaceutical-innovation

More Than 50 Medicines in Development for COPD, Third Leading Cause of Death in U.S.

PhRMA  |  Press Release

PhRMA companies are leading the way in the search for new cures.
https://www.phrma.org/press-release/more-than-50-medicines-in-development-for-copd-third-leading-cause-of-death-in-u-s

RxE HCV in Indiana

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-indiana

190 Medicines in Development for Heart Disease and Stroke

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/190-medicines-in-development-for-heart-disease-and-stroke

Medicare Monday: Did you know … ?

PhRMA  |  Blog Post

For more videos on Part D, click .youtube.com/playlist?
http://catalyst.phrma.org/medicare-monday-did-you-know

PhRMA Announces Support for Seven-Day Script Limit on Opioid Medicines for Acute Pain

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit:  www.PhRMA.org .innovation.org/?
https://www.phrma.org/press-release/phrma-announces-support-for-seven-day-script-limit-on-opioid-medicines-for-acute-pain

HIV Aids In this Together

PhRMA  |  Report

This week, at the 2014 Research and Hope Awards, we are coming together to recognize those who have helped lead the fight against HIV/AIDS.
https://www.phrma.org/report/hiv-aids-in-this-together

Nearly 300 Medicines in Development to Treat Two Leading Causes of Death

PhRMA  |  Press Release

Last year, cardiovascular disease cost American society more than $503 billion, including treatment for those who have survived heart attacks and strokes.
https://www.phrma.org/press-release/nearly-300-medicines-in-development-to-treat-two-leading-causes-of-death

Commercially-Insured Patients Pay Undiscounted List Prices for One In Five Brand Prescriptions, Accounting for Half of Out-of-Pocket Spending on Brand Medicines

PhRMA  |  Report

In the commercial market, one in five prescriptions for brand medicines are filled in the deductible or with coinsurance and cost-sharing for these prescriptions accounts for more than half of patients’ total out-of-pocket spending on brand medicines.
https://www.phrma.org/report/commercially-insured-patients-pay-undiscounted-list-prices-for-one-in-five-brand-prescriptions-accounting-for-half-of-out-of-pocket-spending-brand-medicines

Greatest Hit for the Week

PhRMA  |  Blog Post

Have a great weekend.
http://catalyst.phrma.org/greatest-hit-for-the-week

PhRMA and BIO Initiate Litigation to Challenge Unconstitutional Provisions of Nevada’s SB 539

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org/phrma-bio-release

You have reviewed the first 75 results out of 2565. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next